How High Can TPO Antibodies Go and What Do They Mean?

TPO antibody levels can climb remarkably high. In patients with Hashimoto’s thyroiditis, measured values have reached up to 90,000 U/mL, while in Graves’ disease they have been recorded as high as 74,000 U/mL. Most lab reference ranges set the upper “normal” cutoff somewhere between 35 and 100 IU/mL depending on the assay, so these extreme titers represent levels hundreds of times beyond that threshold. What those numbers actually tell you about your health, though, is more nuanced than a simple “higher is worse” story.

What TPO Antibodies Actually Are

Thyroid peroxidase, or TPO, is the enzyme your thyroid gland uses to produce thyroid hormones.¹ It sits on the surface of thyroid cells and is essential for attaching iodine to the building blocks of T3 and T4, the hormones that regulate your metabolism, energy, and body temperature. In autoimmune thyroid disease, the immune system mistakenly recognizes TPO as a threat and produces antibodies against it. These antibodies are high-affinity IgG-class immunoglobulins, and their presence is a reliable marker that the immune system has begun infiltrating the thyroid gland.² The resulting immune attack, carried out in part by T cells that are also directed against TPO, is what gradually damages and destroys thyroid tissue over time.

The Full Spectrum of TPO Antibody Levels

One of the confusing things about TPO antibody testing is that different labs use different assays, and each assay has its own scale and upper detection limit. A result of 500 IU/mL on one test is not necessarily equivalent to 500 U/mL on another. That said, a landmark study measuring anti-TPO antibodies across various thyroid conditions gives a useful sense of the range. In healthy controls, only about 8% tested positive at all, and their levels topped out at 210 U/mL. In Hashimoto’s thyroiditis and related severe autoimmune hypothyroidism, nearly all patients tested positive, with values stretching up to 90,000 U/mL. Graves’ disease patients showed positivity in about three-quarters of cases, with levels reaching 74,000 U/mL. People with non-autoimmune thyroid conditions and those with thyroid cancer had far lower antibody levels when positive, generally staying below 7,000 U/mL.³

So there is no real ceiling on how high TPO antibodies can go, but the extremely high numbers are most characteristic of Hashimoto’s thyroiditis, the most common autoimmune thyroid condition. Values in the tens of thousands are unusual but not unheard of, and they almost always point to an active autoimmune assault on the thyroid gland.

Do Higher Levels Mean Worse Disease?

This is the question most people want answered after seeing a sky-high number on their lab results. The short answer is: roughly yes, but with important caveats. Research has shown that higher TPO antibody titers correlate with increased frequencies of immune cells producing inflammatory cytokines in the thyroid, the very cells responsible for damaging and killing thyroid tissue in Hashimoto’s disease.⁴ In practical terms, this means that higher antibodies generally reflect a more aggressive immune attack.

A 2024 study added another dimension to this picture by looking at how TPO antibody levels relate to everyday symptoms. As antibody levels climbed, patients reported worsening bloating, diarrhea, sensitivity to cold, facial puffiness, forgetfulness, swelling, weight gain, and dry skin.⁵ These are classic hypothyroid symptoms, and the fact that they tracked with antibody levels (not just with thyroid hormone levels) suggests the immune activity itself contributes to how people feel, beyond just hormone disruption.

That said, the correlation is loose enough that individual cases vary widely. Some people with TPO antibodies in the thousands feel perfectly fine and maintain normal thyroid hormone levels for years. Others with more moderate antibody levels develop significant hypothyroidism quickly. The antibody number is one piece of the puzzle, not a definitive score of illness severity.

When Very High Levels Warrant Extra Attention

There is one clinical scenario where extremely high TPO antibodies carry a specific warning. A study of patients with Hashimoto’s thyroiditis who also developed papillary thyroid cancer found that antibody levels above 1,300 IU/mL were strongly associated with having multiple tumor foci rather than a single one. In the group with multifocal cancer, about 84% had levels above that threshold, compared to fewer than 1% of those with a single tumor focus.⁶ This finding is relevant mainly for surgical planning in the small subset of Hashimoto’s patients who also have thyroid cancer. It is not a reason for a typical Hashimoto’s patient to panic about their antibody number, but it illustrates that in specific clinical decisions, the height of the titer can carry practical weight.

Positive Antibodies With Normal Thyroid Function

A surprisingly common scenario is testing positive for TPO antibodies while your thyroid hormones are still in the normal range. Roughly 12 to 26% of people with normal thyroid function have detectable TPO antibodies, depending on the sensitivity of the test used.⁷ This does not mean those antibodies are meaningless. Even when thyroid hormones look normal, TPO antibody levels correlate with the degree of immune cell infiltration into the thyroid and with slightly higher TSH levels, suggesting the gland is already under strain.

The practical concern is future risk. In the well-known Whickham Survey, women with positive TPO antibodies and normal TSH had an annual risk of developing overt hypothyroidism of about 2.1%.⁷ That may sound small year to year, but it adds up. Over a decade, roughly one in five of those women would be expected to develop thyroid failure. This is why many endocrinologists recommend periodic TSH monitoring for anyone who tests positive for TPO antibodies, even if everything else looks fine.

TPO Antibodies in Graves’ Disease

People often associate TPO antibodies exclusively with Hashimoto’s, but they show up frequently in Graves’ disease too. Studies have found that roughly 59 to 72% of Graves’ patients are TPO antibody positive at diagnosis.⁸ Graves’ disease is driven by a different antibody, TSH receptor antibodies (TRAb), which stimulate the thyroid to overproduce hormones. But the co-occurrence of TPO antibodies in Graves’ patients tells a more complicated immune story.

Research from Basrah found that Graves’ patients who were also TPO-positive had higher baseline TRAb levels and higher free thyroxine at diagnosis, suggesting a more intense form of the disease.⁹ A separate study found that TPO-positive Graves’ patients tended to need longer treatment to achieve remission compared to those positive only for thyroglobulin antibodies.¹⁰ So while TPO antibodies in Graves’ disease do not predict whether the disease will relapse on their own, they are associated with a more stubborn clinical course.

Pregnancy, Miscarriage, and Postpartum Risk

TPO antibodies take on added significance during and after pregnancy. Women who test positive for TPO antibodies have a higher risk of recurrent pregnancy loss, and this holds true even when their thyroid hormone levels are normal.¹¹ A study of euthyroid women with unexplained recurrent miscarriage found that those who were TPO antibody positive had a first-trimester miscarriage rate of about 37%, compared to 24% in those who were negative. Among women under 35, the disparity was even starker: roughly 33% versus 19%.¹²

After delivery, TPO antibody levels are a strong predictor of postpartum thyroiditis, a condition where the thyroid swings between overactivity and underactivity in the months following birth. Women who had higher antibody levels during the postpartum period were far more likely to develop long-term thyroid dysfunction. Those with both postpartum thyroiditis and high TPO antibodies had a relative risk of persistent thyroid problems 32 times higher than women who were antibody-negative.¹³ A 2024 study confirmed this trajectory effect, finding that women whose TPO antibody levels stayed on a higher track throughout pregnancy and the postpartum period were more likely to be hypothyroid a year after giving birth.¹⁴

What Drives TPO Antibodies Up in the First Place

Autoimmune thyroid disease requires a genetic predisposition, but something in the environment usually flips the switch. The best-established trigger is excess dietary iodine. In populations that have increased their iodine intake, rates of thyroid autoimmunity tend to rise, but only in people who are genetically susceptible.¹⁵ Animal studies have reinforced this link, showing that depleting iodine from the thyroid can actually prevent disease in strains prone to severe thyroiditis.¹⁶

Iodine is far from the only suspect. Industrial chemicals, including polyaromatic hydrocarbons, polybrominated biphenyls, and polychlorinated biphenyls, can affect thyroid function or promote immune dysfunction. Infections have also been implicated, potentially acting alone or in combination with environmental exposures.¹⁵ Smoking, stress, and certain medications (particularly amiodarone and lithium, both of which contain or affect iodine processing) are other recognized contributors, though the strength of evidence varies.

The genetic component is substantial. A large genome-wide study identified nine genetic regions significantly associated with TPO antibody levels, including loci in the HLA region that controls immune self-recognition. People whose genetic profile placed them in the highest risk quartile had about 1.8 times the odds of developing subclinical hypothyroidism and nearly 1.9 times the odds of overt hypothyroidism compared to those in the lowest-risk quartile.¹⁷ This helps explain why autoimmune thyroid disease clusters in families and why some people seem to develop it without any obvious trigger.

Can You Lower TPO Antibodies?

This is often the first question people ask after a Hashimoto’s diagnosis, and the evidence here is genuinely encouraging for some interventions. Levothyroxine, the standard treatment for hypothyroidism, does more than just replace missing thyroid hormones. In a long-term follow-up study, 92% of Hashimoto’s patients on levothyroxine saw their TPO antibody levels decrease. The average starting level was around 4,800 IU/mL. After one year, antibodies had dropped by about 45%, and after five years they were down roughly 70%. That said, antibodies fully normalized (below 100 IU/mL) in only about 16% of patients, so most people still test positive even after substantial improvement.¹⁸

Selenium supplementation has attracted considerable attention. A meta-analysis of randomized trials found that selenium significantly reduced TPO antibody levels after three months and even more after six months of supplementation.¹⁹ One of the earlier and most cited trials in this area gave patients 200 micrograms of sodium selenite daily and found that TPO antibodies dropped to about 64% of their starting level after three months, versus essentially no change with placebo. In the subgroup with the highest antibodies (above 1,200 IU/mL), selenium produced a 40% reduction while the placebo group actually saw a 10% increase.²⁰

Dietary changes are harder to study rigorously, but a pilot study in women with Hashimoto’s and subclinical hypothyroidism found that combining selenium supplementation with a gluten-free diet reduced TPO antibodies by about 49% over six months, compared to 34% with selenium alone.²¹ A meta-analysis looking at gluten-free diets in autoimmune thyroiditis patients without confirmed celiac disease found that antibody reductions were more pronounced in patients who also happened to have a gluten-related condition, suggesting the benefit may not extend to everyone.²² The honest take: selenium has decent evidence behind it, and a gluten-free diet may help a subset of people, but neither is a guaranteed fix.

Why Your Doctor May Not Care About the Exact Number

After absorbing all of this, you might be surprised to learn that most endocrinologists spend relatively little time discussing your specific TPO antibody number. There is a reason for that. In routine clinical practice, the antibody test is primarily used as a yes-or-no diagnostic tool: are you positive, confirming autoimmune thyroid disease, or negative? Once the diagnosis is established, treatment decisions are driven mainly by your TSH and free T4 levels, not by tracking antibody titers over time.

The exceptions to this are the scenarios covered above: pregnancy planning, postpartum monitoring, and the rare surgical decision where an extremely high titer alters the approach. Outside of those contexts, chasing a lower antibody number for its own sake is not a standard treatment goal, because there is no strong evidence that reducing the antibody titer independently improves thyroid function or long-term outcomes. The antibody level reflects what the immune system is doing, but it is the downstream effects on thyroid hormone production that actually determine how you feel and what treatment you need.

This disconnect between the alarming-looking lab number and the clinical reality is a source of ongoing frustration for patients. Seeing a number in the thousands when the reference range says it should be under 35 understandably feels urgent. The reality is that your immune system’s activity fluctuates, antibody levels can swing by hundreds or even thousands of units between tests, and the number on any single draw is a snapshot rather than a verdict. If your thyroid hormones are well-controlled and you feel well, a high antibody number alone does not typically change your treatment plan.

Fluctuations and Retesting

TPO antibody levels are not static. They can rise during periods of immune activation, including illness, pregnancy, and stress, and fall during others. Seasonal variation has even been reported in some studies. The levothyroxine data mentioned earlier shows the general trajectory in treated Hashimoto’s: a gradual decline over years, punctuated by individual variation. Some patients saw undulating levels that bounced up and down before trending lower, and one patient in that study actually had antibodies that climbed over time despite treatment.¹⁸

Because of this variability, retesting TPO antibodies more often than every six to twelve months rarely provides useful information. A single high reading does not mean the disease is spiraling, and a single drop does not mean remission. The trend over years is more meaningful than any individual result. For most people, the more actionable number to track regularly is TSH, which directly reflects how well the thyroid is meeting the body’s hormone needs at that moment.